Patents/Assignees

Curevac SE

55 patents in portfolio

US12618060utility2026
Nucleic Acid Molecules
0 cites
US12612654utility2026
Method for Analyzing RNA
0 cites
US12589078utility2026
Lipid Nanoparticles for Delivery of Nucleic Acids
0 cites
US12533422utility2026
Modified RNA with Decreased Immunostimulatory Properties
0 cites
US12527856utility2026
Artificial RNA Molecules Encoding a Norovirus Antigen and Uses Thereof
0 cites
US12528855utility2026
KRAS Variant Mrna Molecules
0 cites
US12508308utility2025
Influenza Mrna Vaccines
0 cites
US12492425utility2025
Methods for RNA Analysis
0 cites
US12460204utility2025
Artificial Nucleic Acid Molecules for Improved Protein or Peptide Expression
0 cites
US12442005utility2025
Artificial Nucleic Acid Molecules for Improved Protein Expression
0 cites
US12397048utility2025
Bunyavirales Vaccine
0 cites
US12390523utility2025
Coronavirus Vaccine
0 cites
US12385088utility2025
Linear Double Stranded DNA Coupled to a Single Support or a Tag and Methods for Producing Said Linear Double Stranded DNA
0 cites
US12371699utility2025
Nucleic Acids Encoding Crispr-associated Proteins and Uses Thereof
0 cites
US12350330utility2025
RSV RNA Molecules and Compositions for Vaccination
0 cites
US12337031utility2025
Combination Vaccine
0 cites
US12318486utility2025
Dry Powder Composition Comprising Long-chain RNA
0 cites
US12258567utility2025
Artificial Nucleic Acid Molecules
0 cites
US12240873utility2025
Respiratory Syncytial Virus (RSV) Vaccine
0 cites
US12227549utility2025
RNA Encoding a Therapeutic Protein
0 cites

Page 1 of 3Next →